Kalkine Earnings
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 446
- Sources here
- 17
- Companies here
- 15
Active search
446 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Atlanticus (NASDAQ:ATLC) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen has upgraded Atlanticus (NASDAQ:ATLC) stock rating from "buy" to "strong-buy," aligning with a broader "Moderate Buy" consensus from analysts with an average price target of $126. This upgrade follows Atlanticus exceeding its quarterly earnings expectations, reporting $2.50 EPS on $744.31 million …
Q1 2026 ICU Medical Inc Earnings Call Transcript
This article provides the edited transcript of ICU Medical Inc.'s Q1 2026 earnings call, which took place on May 7, 2026. The call began with an introduction from an unidentifiable speaker, followed by Thompson from ICR who welcomed participants to discuss the financial results. …
Assenagon Asset Management S.A. Buys New Position in AtriCure, Inc. $ATRC
Assenagon Asset Management S.A. has initiated a new position in AtriCure, Inc. (NASDAQ:ATRC), purchasing 62,334 shares valued at approximately $1.74 million. This move comes as AtriCure reported strong quarterly earnings, exceeding revenue estimates with $153.6 million and achieving an EPS of $0.18. Despite positive …
Atlanticus Holdings Corp (ATLC) Shares Surge 5.7% -- What GF Sco
Atlanticus Holdings Corp (ATLC) shares rose 5.7% to $102.53, with GuruFocus identifying the stock as 40.5% undervalued compared to its GF Value™ of $172.26. Despite a strong GF Score™ of 66/100 and high momentum, the company faces concerns regarding its low financial strength (2/10) …
AtriCure (ATRC) Is Up 10.1% After Unveiling 2030 Revenue Goal And Trial-Driven Expansion Plans
AtriCure (ATRC) saw a 10.1% stock increase after announcing a goal of US$1.00 billion in revenue by 2030, driven by its atrial fibrillation, left atrial appendage management, and postsurgical pain-management franchises, alongside new product launches. The company's expansion plans heavily rely on the successful …
Fuller & Thaler boosts disclosure of 5.19% ICU Medical (ICUI) ownership stake
Fuller & Thaler Asset Management, Inc. has filed an amended Schedule 13G, disclosing a 5.19% beneficial ownership stake in ICU Medical (ICUI). The firm holds 1,298,126.96 shares, with sole voting power over 1,276,819.96 shares and sole dispositive power over all 1,298,126.96 shares. The filing, …
EXICURE, INC. Q2 2026: Revenue $0 Net income $(1.12M) — 10-Q Summary
EXICURE, INC. reported Q2 2026 results with no revenue and a net loss of $(1.12M), an improvement year-over-year. The company has shifted its strategic focus to supporting clinical programs for GPCR USA post-acquisition, implementing operational cutbacks, and addressing Nasdaq compliance issues. Financial highlights include …
Fort Baker Capital discloses 4.2% ANSC stake in Schedule 13G/A filing (ANSC)
Fort Baker Capital Management LP, along with Steven Patrick Pigott and Fort Baker Capital, LLC, has reported a beneficial ownership of 1,379,630 Class A ordinary shares in Agriculture & Natural Solutions Acquisition Corp (ANSC). This stake represents 4.2% of the outstanding Class A shares, …
ICU Medical (ICUI) Insider Sells 5,417 Shares: VP, GM-Infusion Capital Daniel Woolson Reduces Stake
Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc (ICUI), sold 5,417 shares of the company on August 13, 2026, bringing his total ownership to 17,062 shares. This transaction is part of a trend where insiders at ICU Medical have generally been selling more …
Sell Alert: Daniel Woolson Cashes Out $982K In ICU Medical Stock
Daniel Woolson, VP at ICU Medical (NASDAQ: ICUI), recently sold 5,417 shares of the company's stock for a total transaction value of $982,264, as disclosed in an SEC filing. This insider transaction occurred on August 13, leading to a slight dip in ICU Medical's …
Form 8K FEDERAL AGRICULTURAL MORTGAGE CORPORATION For: 14 August By Investing.com
This article reports that FEDERAL AGRICULTURAL MORTGAGE CORPORATION has filed a Form 8K on August 14. The filing is brief and primarily serves as a notification of the SEC document. The article includes general market data and related news but offers no further details …
Atlanticus (ATLC) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Jeffrey HowardChief Financial Officer - William McCamey TAKEAWAYS Total Operating Revenue and Other Income -- $744.3 million, an 89% increase from the …
ICU Medical VP Daniel Woolson sells $982,264 in stock
Daniel Woolson, VP, GM-Infusion Capital at ICU Medical Inc. (NASDAQ:ICUI), sold 5,417 shares of the company's common stock for $982,264 on August 13, 2026, at $181.33 per share. This sale occurred as ICUI shares are near their 52-week high, following strong Q2 results where …
ICU Medical (ICUI) officer Daniel Woolson sells 5,417 shares at $181.33
Daniel Woolson, VP and GM-Infusion Capital at ICU Medical Inc. (ICUI), sold 5,417 shares of common stock at $181.33 per share on August 13, 2026. After this transaction, Woolson directly holds 17,062 shares of ICU Medical common stock. The sale was not conducted under …
Atlanticus Holdings Corporation Declares Quarterly Dividend on Series B Cumulative Perpetual Preferred Stock
Atlanticus Holdings Corporation announced a quarterly dividend of $0.476563 per share for its Series B Cumulative Perpetual Preferred shareholders, payable on or about September 15, 2026, to shareholders of record by September 1, 2026. The company focuses on providing inclusive financial services and has …
Atlanticus Schedules Preferred Dividend Cash Payment Around Sept. 15
Atlanticus Holdings Corporation announced that its Board of Directors approved a quarterly cash dividend of $0.476563 per share for holders of its Series B Cumulative Perpetual Preferred Stock. The dividend is scheduled to be paid on or about September 15, 2026, to shareholders of …
Wellington Group discloses 3.46% Atlanticus (ATLC) position held for advisory clients
Wellington Management Group LLP and its related entities have filed an amended Schedule 13G, disclosing a 3.46% beneficial ownership stake in Atlanticus Holdings Corporation (ATLC). This position, totaling 522,642 shares, is held for advisory clients of Wellington's investment advisers, who retain the rights to …
Janus Henderson holds 11.1% of ICU Medical (ICUI) common stock via clients
Janus Henderson Group Ltd. has reported a beneficial ownership of 2,781,621 shares of ICU Medical, Inc. common stock, which constitutes 11.1% of the class. These shares are held through various Managed Portfolios where Janus Henderson's affiliated Asset Managers exercise investment and voting discretion, though …
Atlanticus Holdings Corp (ATLC) Q1 2026 Earnings Report - Results, Call & Slides
Atlanticus Holdings Corp (ATLC) released its Q1 2026 earnings report, showing an actual EPS of $2.23, beating the consensus of $1.69. However, the actual revenue of $679.59M missed the expected revenue of $749.36M. The company's next earnings report is estimated for November 5, 2026.
ICU Medical Inc (ICUI) Chief Information Officer Ben Sousa Sells 2,250 Shares
ICU Medical Inc's Chief Information Officer, Ben Sousa, sold 2,250 shares of the company's stock for approximately $401,220. This transaction contributes to a trend of insider selling at the company, with 9 sells versus 2 buys over the last year. The stock is currently …
The 5 Most Interesting Analyst Questions From ICU Medical’s Q2 Earnings Call
ICU Medical (ICUI) reported strong Q2 CY2026 results, exceeding analyst expectations for revenue, adjusted EPS, and EBITDA, driven by robust performance in Infusion Systems and Consumables. The article highlights key analyst questions from the earnings call, focusing on the drivers of Infusion Systems growth, …
AtriCure, Inc. - Common Stock (ATRC) Stock Price, News, Quote & History
This page provides a comprehensive overview of AtriCure, Inc. (ATRC) stock, including its current price, key financial metrics, and recent news. AtriCure is a medical device company specializing in treatments for atrial fibrillation and other cardiac conditions, focusing on minimally invasive surgical procedures. The …
SeaStar Medical (ICU) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Wednesday, Aug. 12, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer - Eric SchlorffSenior Vice President of Commercial and Business Operations - Tim VaracekChief Medical Officer - Kevin ChungChief Financial Officer - Michael Messinger TAKEAWAYS Net …